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Abstract
Arsenic methyltransferase (As3mt) catalyzes the conversion of inorganic arsenic (iAs) to its 
methylated metabolites, including toxic methylarsonite (MAsIII) and dimethylarsinite (DMAsIII). 
Knockout (KO) of As3mt was shown to reduce the capacity to methylate iAs in mice. However, no 
data are available on the oxidation states of As species in tissues of these mice. Here, we compare 
the oxidation states of As species in tissues of male C57BL/6 As3mt-KO and wild-type (WT) 
mice exposed to arsenite (iAsIII) in drinking water. WT mice were exposed to 50 mg/L As and 
As3mt-KO mice that cannot tolerate 50 mg/L As were exposed to 0, 15, 20, 25 or 30 mg/L As. 
iAsIII accounted for 53% to 74% of total As in liver, pancreas, adipose, lung, heart, and kidney of 
As3mt-KO mice; tri- and pentavalent methylated arsenicals did not exceed 10% of total As. 
Tissues of WT mice retained iAs and methylated arsenicals: iAsIII, MAsIII and DMAsIII 
represented 55%–68% of the total As in the liver, pancreas, and brain. High levels of methylated 
species, particularly MAsIII, were found in the intestine of WT, but not As3mt-KO mice, 
suggesting that intestinal bacteria are not a major source of methylated As. Blood of WT mice 
contained significantly higher levels of As than blood of As3mt-KO mice. This study is the first to 
determine oxidation states of As species in tissues of As3mt-KO mice. Results will help to design 
studies using WT and As3mt-KO mice to examine the role of iAs methylation in adverse effects of 
iAs exposure.
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Introduction
Inorganic arsenic (iAs), a potent human carcinogen, is ubiquitous in the environment and 
accumulates in aquifers naturally and through anthropogenic activities. The ingestion of iAs 
through contaminated drinking water, most commonly as arsenite (iAsIII) and arsenate 
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(iAsV), has been associated with numerous adverse effects, including peripheral vascular 
disease, hypertension, and cancer of the lungs, liver, and bladder (Tseng et al., 2007; Wang 
et al., 2007a; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans et 
al., 2004). A recent National Toxicology Program workshop examining the effects of 
environmental chemicals on the development of diabetes and obesity concluded that there 
was sufficient evidence to link iAs exposures to an increased risk of diabetes in populations 
exposed to high levels of iAs in drinking water (Maull et al., 2012).
The enzyme, arsenic (+3 oxidation state) methyltransferase (AS3MT) catalyzes the S-
adenosylmethionine (SAM)-dependent methylation of iAs to tri- and pentavalent methylated 
metabolites (Thomas, 2004). AS3MT mRNA has been found in several human and rodent 
tissues, including, liver, kidney, urinary bladder, heart, lung, testes, and adrenal gland (Lin et 
al., 2002). Once ingested, iAs is sequentially methylated by AS3MT producing 
methylarsonite (MAsIII), methylarsonate (MAsV), dimethylarsinite (DMAsIII), 
dimethylarsinate (DMAsV), and trimethylarsine oxide (TMAsVO). Growing evidence 
suggests that the methylated trivalent As (AsIII) species, MAsIII and DMAsIII, produced in 
the course of iAs metabolism, are more toxic than iAs or their pentavalent counterparts 
(Thomas et al., 2001; Lin et al., 2001; Drobna et al., 2003; Wang et al., 2007b; Douillet et 
al., 2013).
Laboratory-based studies have shown that iAs exposure alters glucose homeostasis and 
several mechanisms regulating glucose metabolism. Specifically, in our studies, exposure to 
subtoxic concentrations of iAsIII, MAsIII or, DMAsIII inhibited glucose-stimulated insulin 
secretion by isolated murine pancreatic islets without affecting basal insulin secretion or 
insulin content and expression, suggesting that AsIII species inhibit insulin transport vesicle 
packaging or translocation to the plasma membrane (Douillet et al., 2013). In β-cell lines 
exposed to iAs, an impairment of glucose-stimulated insulin secretion has been associated 
with reduced insulin expression (Díaz-Villaseñor et al., 2006) alterations in Ca2+ oscillations 
(Diaz-Villasenor et al., 2008), or with an Nrf2-mediated antioxidant response suppressing 
endogenous reactive oxygen species (Yen et al., 2007; Fu et al., 2010) that may be required 
for insulin secretion (Pi and Collins, 2010). In other cell culture models, iAsIII has been 
shown to inhibit differentiation of adipocytes (Trouba et al., 2000; Wauson et al., 2002) and 
myotubes (Steffens et al., 2011), the cell types that are involved in glucose utilization in 
vivo. Moreover, we have shown that AsIII species inhibit insulin signaling and insulin-
stimulated glucose uptake in cultured differentiated adipocytes (Paul et al., 2007a; Walton et 
al., 2004). We have also shown that in C57BL/6 mice exposure to 50 mg/L As as iAsIII in 
drinking water resulted in impaired glucose tolerance (Paul et al., 2007b, 2011). Notably, 
mice chronically exposed to iAsIII in combination with high-fat diet produced a unique 
diabetic phenotype characterized by impaired glucose tolerance in the absence of significant 
obesity and insulin resistance (Paul et al., 2011), suggesting that the mechanisms underlying 
As-induced diabetes differ from those responsible for development of the obesity-associated 
type 2 diabetes.
Genetically altered, C57BL/6 As3mt-knockout (KO) mice have been recently developed and 
partially characterized (Drobna et al., 2009). When exposed to iAs these mice retained 
significantly more As than WT mice (Chen et al., 2011; Drobna et al., 2009; Hughes et al., 
Currier et al. Page 2
J Environ Sci (China). Author manuscript; available in PMC 2017 March 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
2010) and exhibited increased sensitivity to iAs toxicity (Yokohira et al., 2010, 2011). 
Chemical analyses have shown that iAs was the predominant species in tissues of As3mt-
KO mice exposed to iAs; however, methylated As metabolites were detected in liver and 
plasma, suggesting the methylation of iAs by other methyltransferases or by intestinal 
microbiota (Drobna et al., 2009; Naranmandura et al., 2012). The oxidation states of iAs or 
the methylated As species found in tissues of As3mt-KO mice have never been determined. 
In spite of this information gap, the As3mt-KO mice have been used as a laboratory model 
to explore the role of iAs methylation and the contribution of trivalent methylated arsenicals 
in the development of iAs-induced diseases.
Hydride generation-cryotrapping-atomic absorption spectrometry (HG-CT-AAS) is uniquely 
suited for the oxidation state specific speciation analysis of As in complex biological 
matrices. The analysis using HG-CT-AAS does not require sample pretreatment or 
extraction, thus preserving the methylation state of unstable MAsIII and DMAsIII (Matoušek 
et al., 2008; Hernández-Zavala et al., 2008; Currier et al., 2011a, 2011b). This method has 
been successfully used to determine concentrations of the methylated trivalent arsenicals, 
MAsIII and DMAsIII, in human urine (Del Razo et al., 2001, 2011; Valenzuela et al., 2004, 
2009), mouse tissues (Currier et al., 2011a, 2011b), in vitro cell cultures (Del Razo et al., 
2001; Hernández-Zavala et al., 2008) and in vitro mixtures for methylation of iAs by 
recombinant AS3MT (Hernández-Zavala et al., 2008; Ding et al., 2012). In this study, we 
used HG-CT-AAS to characterize the retention of tri-and pentavalent arsenicals in tissues of 
wild-type (WT) and As3mt-KO C57/BL6 mice after exposure to iAsIII.
1. Materials and methods
1.1. Arsenicals
The following pentavalent arsenicals were used for calibration during the HG-CT-AAS 
analysis: sodium arsenite (NaAsIIIO2) and sodium arsenate (Na2HAsVO4) (both ≥ 99% 
pure) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Methylarsonic acid, 
disodium salt (CH3AsVO(ONa)2), and dimethylarsinic acid ((CH3)2AsVO(OH)), both better 
than 98% pure, were purchased from Chem Service (West Chester, PA, USA). The As 
content in each of the standards was determined by graphite furnace-AAS (Matoušek et al., 
2008).
1.2. Mice and treatments
All procedures involving mice were approved by the University of North Carolina 
Institutional Animal Care and Use Committee. The As3mt-KO mouse colony has been 
established at UNC using breeding pairs provided by Dr. David Thomas, U.S. EPA. In this 
study, 13- to 18-week old male C57BL/6 As3mt-KO mice were used along with 13–17 week 
old male WT C57BL/6J mice from Jackson Laboratory (Bar Harbor, ME, USA). All mice 
were housed in polycarbonate cages (5 per cage) with corn cob bedding at the University of 
North Carolina Animal Facility (12 hr light/dark cycle, 22 ± 1°C and humidity 50% ± 10%). 
Mice were fed Lab Diet 5058 (Nutrition International, Brentwood, MO, USA) and drank 
pure deionized water (DIW) or DIW containing iAsIII ad libitum for the 4-week study 
period. As3mt-KO mice were exposed to 0, 15, 20, 25, or 30 mg/L As as iAsIII (n = 5 per 
Currier et al. Page 3
J Environ Sci (China). Author manuscript; available in PMC 2017 March 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
treatment group). WT mice were exposed to 50 mg/L As (n = 10), the dose that previously 
produced a diabetic phenotype in this mouse strain (Paul et al., 2007b). The concentration of 
iAs in water in all treatment groups was verified by HG-CT-AAS analysis. Mice were 
euthanized by cervical dislocation. Freshly dissected tissues were processed as previously 
described, and tissue homogenates were prepared in ice cold DIW (10%, W/V) using an 
electrical overhead stirrer equipped with a Teflon pestle tissue homogenizer (Wheaton 
Industries, Inc., Millville, NJ, USA) (Currier et al., 2011b).
1.3. Speciation analysis of As by HG-CT-AAS
Arsenic species were analyzed by an optimized method for the oxidation state specific 
analysis of As species in biological matrices (Matoušek et al., 2008; Hernández-Zavala et 
al., 2008; Currier et al., 2011a, 2011b). Briefly, HG-CT-AAS analysis was performed using 
a FIAS 400 flow injection accessory (Perkin-Elmer, Norwalk, CT, USA) coupled to a 
cryotrapping unit and an AAnalyst 800 spectrometer (Perkin-Elmer) equipped with a 
multiple microflame quartz tube atomizer (multiatomizer) (Matoušek et al., 2008; 
Hernández-Zavala et al., 2008). To measure the oxidation state of As species, two aliquots of 
each sample are analyzed; arsine gases from trivalent arsenicals (iAsIII, MAsIII and 
DMAsIII) and from TMAsVO are generated directly at pH 6, while arsines from both tri- and 
pentavalent arsenicals (iAsIII+V, MAsIII+V and DMAsIII+V) are measured after pre-reduction 
for 1 hr at room temperature with 2% L-cysteine (EMD Chemicals Inc., Gibbstown, NJ, 
USA) (Matoušek et al., 2008; Hernández-Zavala et al., 2008). The pre-reduction, however, 
results in loss of TMAsVO. The concentrations of the pentavalent iAsV, MAsV, and DMAsV 
are calculated by subtracting the AAS peak area signals obtained for L-cysteine-treated and 
directly analyzed, untreated sample aliquots. Calibration curves for quantification of tri- and 
pentavalent As species were generated using aqueous solutions of the pentavalent standards 
(iAsV, MAsV, and DMAsV) pre-treated with 2% L-cysteine. Notably, results of our 
published work shows that HG-CT-AAS analyses of crude tissue homogenates result in high 
(~80%–100%) recoveries of As (Currier et al., 2011b).
1.4. Statistical analysis
All statistical analyses were performed using GraphPad Instat software package (GraphPad 
Software Inc., San Diego, CA, USA). Linear regression and correlation analyses were 
employed to characterize the calibration curves using aqueous pentavalent As standards. 
ANOVA followed by Bonferroni’s multiple comparison post-test was used to determine 
significant differences between As3mt-KO and WT mice for each of the measured 
endpoints. Statistical significance was considered at the level of p < 0.05.
2. Results and discussion
2.1. Water consumption and body weights
The consumption of water for each exposure group and individual body weights were 
measured weekly throughout the study. Fig. 1 depicts the estimated daily water consumption 
and the corresponding iAs intake for each exposure group over the 4-week study period. 
Water intake increased after the first week and then plateaued for the remaining study period 
except in As3mt-KO mice exposed to 25 mg/L As, which exhibited decreased water 
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consumption in weeks 3 and 4 (Fig. 1a). The As3mt-KO mice exposed to pure DIW 
consumed significantly more water than all iAs-treated groups (Fig. 1a and b). As3mt-KO 
mice exposed to 15, 20, 25, or 30 mg/L As ingested approximately 27.1, 34.9, 43.4, and 42.7 
μg of iAs/day, respectively, while WT mice exposed to 50 mg/L As ingested approximately 
107.6 μg of iAs/day (Fig. 1c). There was no significant difference in iAs/day ingestion 
among the As3mt-KO groups, but the WT group ingested significantly more iAs than all 
other groups. We have previously shown that WT mice exposed to 50 mg/L As could taste 
the high concentration As and drank less water than WT mice at lower exposure levels or 
unexposed mice (Paul et al., 2007b, 2011). The current data suggest that KO mice are even 
more sensitive to As and further limit the water consumption.
The body weight of each mouse was measured prior to iAs exposure and weekly throughout 
the study. On average, all mice gained weight except for As3mt-KO mice exposed to 30 
mg/L As (Fig. 2). Unexposed As3mt-KO mice gained an average of 3.2 g over the 4-week 
study period, while As3mt-KO mice exposed to 15, 20, or 25 mg/L As gained an average of 
1.2, 1.6, and 1.1 g, respectively. As3mt-KO mice exposed to 30 mg/L As lost an average of 
1.2 g over the study period. However, no other signs of toxicity were observed during the 
study or in dissected tissues. This is in contrast with previous studies reporting lethality and 
histopathological abnormalities in As3mt-KO mice exposed to 25 mg/L for 4 weeks 
(Yokohira et al., 2011; Chen et al., 2011).
2.2. Effect of genotype on As speciation in tissues
The speciation of As in tissues of As3mt-KO mice has previously been examined. However, 
the analysis was limited to plasma, red blood cells, liver, kidney, lung, and bladder, and did 
not determine the oxidation state of As in the detected As species (Drobna et al., 2009; 
Hughes et al., 2010; Chen et al., 2011). Only recent optimization of the HG-CT-AAS 
method has allowed for the analysis of tri-and pentavalent As species in tissue homogenates 
without sample extractions or digestions that could affect the oxidation state of As. This 
method was used in the present study to compare the speciation of As and to measure the 
concentration of AsIII and AsV species in tissues of As3mt-KO mice and WT mice. As 
expected, iAsIII and iAsV were the main species retained in tissues of As3mt-KO mice, 
while methylated As metabolites predominated in most tissues from WT mice. Fig. 3 
describes the distribution of As species in tissues involved in regulation of glucose 
homeostasis (i.e., liver, adipose tissue, pancreas, and skeletal muscle). As3mt-KO mice 
exposed to 0 mg/L As retained small amounts of iAs, likely due to the presence of iAs in 
standard rodent chow (Paul et al., 2007b). In As3mt-KO mice exposed to iAs in drinking 
water, iAsIII was the predominate species in liver, adipose tissue, and pancreas, representing 
57% to 74% of total speciated As (Fig. 3a–c). In skeletal muscle, iAsIII and iAsV ranged 
from 42% to 53% and 45% to 57% of total speciated As, respectively (Fig. 3d). The 
concentrations of As species in As3mt-KO mice exposed to 15, 20, 25, or 30 mg/L As 
increased in a dose-dependent manner in liver, skeletal muscle and pancreas. In adipose 
tissue, the amount of iAs increased only between 15 and 25 mg/L iAs, but decreased at 30 
mg/L. It is possible that this decrease was associated with the overall toxicity that was 
manifested by decrease in body weight of the As3mt-KO mice exposed to 30 mg/L As. 
DMAsIII was the major As species in the liver and pancreas of WT mice, accounting for 
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29% and 32% of total speciated As respectively. DMAsV represented 45% and 47% of As in 
adipose and skeletal muscle tissues, respectively. Notably, the sum of trivalent species (iAsIII 
+ MAsIII + DMAsIII) accounted for 55% and 68% of As in pancreas and liver of WT mice, 
respectively.
In a previous study of iAs metabolism in As3mt-KO mice, methylated species accounted for 
28% to 32% of total As in liver and 22% to 28% in urine of As3mt-KO mice exposed to a 
single dose of iAsV, suggesting the role of alternative As methylation mechanisms (Drobna 
et al., 2009). However, a more recent study in As3mt-KO mice exposed to iAsIII through 
drinking water (Chen et al., 2011) supports our finding that iAsIII and iAsV are exclusive As 
species retained in liver, with no detectable levels of the methylated metabolites. The 
observed differences may explained by the dosing (single vs. chronic) or by the fact that 
mice were exposed to iAsIII in one study but to iAsV in the other. Notably, in the present 
study, the methylated arsenicals in tissues of As3mt-KO mice never exceeded 10% of the 
total speciated As and no methylated As species were detected in liver, pancreas, or adipose 
tissue.
In addition to the analysis of AsIII and AsV species in the glucose regulating tissues, we also 
performed the oxidation-state analysis of As in the blood. Fig. 4 shows As species in blood 
plasma and blood cells of WT and As3mt-KO mice. Plasma and blood cells of WT mice 
exposed to 50 mg/L As contained significantly more As as compared to any As3mt-KO 
treatment group. In plasma and blood cells of As3mt-KO mice, iAsIII and iAsV were present 
at approximately equal concentrations. An average of 348 ng As/mL was present in plasma 
of WT mice exposed to 50 mg/L As compared with only 6, 17, 21, 33, and 22 ng As/mL in 
As3mt-KO mice exposed to 0, 15, 20, 25 and 30 mg/L As, a greater than 10-fold difference 
(Fig. 4a). In the blood cells of As3mt-KO mice, a dose-dependent increase in As from 15 to 
317 ng As/g tissue was observed, while an average of 506 ng As/g tissue was retained in 
blood cells of WT mice (Fig. 4b). Our finding that WT mice retain more total As in blood 
cells than As3mt-KO mice conflicts with a previous study where WT and As3mt-KO mice 
were exposed to 1, 10, and 25 mg/L As as iAsIII in drinking water for 33 days (Chen et al., 
2011). Here, the authors reported that greater levels of total As were retained by erythrocytes 
of As3mt-KO mice than WT mice. This difference could be associated with differences in 
sample preparation, analytical speciation technique, differences in As recovery, or with 
higher exposures in the present study for WT mice. Notably, the total As level in blood cells 
from As3mt-KO mice exposed to 25 mg/L As in our study (245 ng As/g tissue) is in good 
agreement with the level (~300 μg/L As) reported by Chen et al. (2011).
The concentrations of AsIII and AsV species in several other tissues from WT and As3mt-
KO mice, including intestine, kidney, lung, heart, brain, and testes were also examined (Fig. 
5). Notably, MAsIII accounted for 62% of As in the intestine (with intestinal content 
included) of WT mice exposed to 50 mg/L As (Fig. 5a). In contrast, iAsIII was the 
predominant species in the intestine from As3mt-KO mice while the methylated arsenicals 
represented less than 10% of total speciated As. It has been previously suggested that iAs 
methylation by intestinal bacteria is responsible for the formation of methylated As species 
in As3mt-KO mice (Drobna et al., 2009). Studies in other laboratories have shown that iAs 
can also be methylated by N-6 adenine-specific DNA methyltransferase 1 (Ren et al., 2011). 
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Thus, methylation by intestinal microbiota or other methyltransferases may explain the 
presence of small amounts of the methylated As species in the intestine and in other tissues 
of As3mt-KO mice examined in the present study. Interestingly, total speciated As in the 
intestinal samples averaged between 4040 and 9273 ng As/g in As3mt-KO mice, but 24,879 
ng As/g in WT mice. This data suggests that methylation increases intestinal content and/or 
excretion of As via feces. In a previous study where WT C57/BL6 and As3mt-KO mice 
were repeatedly dosed with 0.5 mg/kg iAsV, whole body As burden and daily excretion 
analysis revealed that WT mice excreted As at least 10 to 20 times faster than As3mt-KO 
mice (Hughes et al., 2010). Our results show that in addition to urine, excretion in feces 
contributes significantly to the clearance of methylated As species from the mouse body.
In the kidney, lung, brain, and testes of As3mt-KO mice, iAsIII accounted for 49% to 81% of 
total speciated As (Fig. 5). In kidney, heart, lung of WT mice, DMAsV accounted for 36%, 
40%, and 63% of speciated As, respectively, while DMAsIII predominated in brain (61%) 
and testes (67%). Notably, total speciated As level in lung from WT mice exposed to 50 
mg/L As was significantly higher than in As3mt-KO mice in any treatment group. A recent 
report indicates significantly higher retention in lungs of As3mt-KO mice exposed to 1 and 
10 mg/L iAsIII compared to WT mice at the same exposures, but not 25 mg/L (Chen et al., 
2011). Our results suggest that at higher exposures, methylated arsenicals are more 
preferentially retained in lung tissue. Overall, these data indicate that trivalent As species are 
highly retained in most tissues of WT and As3mt-KO mice exposed to As and likely play a 
significant role in the development of iAs-induced diseases.
2.3. Comparison of the tissue levels of As
In the present study, we exposed WT C57BL/6J mice to 50 mg/L As in drinking water, the 
dose that produced diabetes in these mice in our previous studies (Paul et al., 2007b, 2011). 
Human exposures are order of magnitude lower. However, mice metabolize iAs more 
efficiently than humans, thus higher doses may be needed in studies using mice to produce 
the effects described in human studies. In fact, total As levels in the livers of mice exposed 
to 50 mg/L in our previous studies (Paul et al., 2007b, 2011) were in the range of the 
concentrations reported in livers of Bangladeshi residents exposed to 0.2–2 mg/L As 
(Mazumder, 2005), indicating that this concentration may be relevant for human exposures.
The As3mt-KO mouse model provides a unique platform to study the adverse effects of 
individual arsenicals because little internal methylation occurs. However, the As3mt 
genotype affects As retention and susceptibility to As-induced toxicity; studies in As3mt-KO 
mice have reported lethality at 50 mg/L As exposures and toxic effects at exposures as low 
as 25 mg/L, concentrations that are well tolerated by WT mice (Yokohira et al., 2010, 2011). 
Thus, to determine which As exposures in As3mt-KO mice yield equivalent internal As 
doses compared to WT mice, As retention in tissues critical for glucose homeostasis (i.e., 
pancreas, liver, skeletal muscle, and adipose tissue; Fig. 3) was examined. Here, differences 
between the sum of iAsIII+V, MAsIII+V, DMAsIII+V and TMAsVO for each As3mt-KO 
group and the WT group exposed to 50 mg/L As were evaluated by one-way ANOVA and 
Bonferroni’s multiple comparison test (Table 1). Total speciated As values for As3mt-KO 
exposure groups that were not significantly different from the 50 mg/L WT group were 
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considered to produce approximately equivalent internal doses. In the pancreas, equivalent 
internal doses to WT mice were only achieved in As3mt-KO mice exposed to 30 mg/L As. 
Equivalent internal As doses in the liver were seen in As3mt-KO mice exposed to 15, 20, 
and 25 mg/L As and for all exposures in adipose tissue. In skeletal muscle, 25 and 30 mg/L 
As exposure in As3mt-KO mice resulted in equivalent internal As doses compared to WT 
mice exposed to 50 mg/L As.
While exposure to 30 mg/L in As3mt-KO mice for 4 weeks produced equivalent total As 
tissue retention in the pancreas, skeletal muscle and adipose, decreased body weights were 
observed in this treatment group after 4 weeks of exposure (Fig. 2). In contrast to other 
studies, no signs of toxicity were observed in any of the other As3mt-KO treatment groups 
(Yokohira et al., 2010, 2011). However, study duration and potential toxicity should be 
carefully considered when planning experiments involving As3mt-KO mice. Therefore, 
exposure to both 25 and 30 mg/L would produce equivalent internal As doses in tissues 
critical for glucose homeostasis and will be used in future studies examining the effects of 
As on the development of diabetes.
3. Conclusions
In As3mt-KO mice exposed to 15, 20, 25, or 30 mg/L As, iAsIII is the most prevalent species 
in liver, pancreas, and adipose tissues. The majority of iAs and methylated As species 
retained in liver and pancreas of WT mice exposed to 50 mg/L As are in the trivalent form. 
DMAsV is the most prevalent species retained in skeletal muscle and adipose tissue of WT 
mice. For tissues critical to glucose homeostasis, doses of 25 and 30 mg/L As as iAsIII will 
produce in As3mt-KO mice total As levels approximately equivalent to those in WT mice 
exposed to the diabetogenic level of 50 mg/L As. These results should be considered when 
designing future studies using As3mt-KO mice to examine then role of iAs metabolism in 
adverse effects associated with iAs exposure.
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Fig. 1. 
Water consumption and iAs intake by As3mt-KO and WT mice. (a) Estimated daily water 
consumption by week for As3mt-KO mice exposed to 0, 15, 20, 25, or 30 mg/L As and 
wild-type (WT) mice exposed to 50 mg/L As. (b) Average daily water consumption per 
mouse for each treatment group. (c) Estimated daily iAs intake per mouse for each treatment 
group. Mean and SD values are shown; n = 5 for each of the As3mt-KO group and n = 10 
for WT group. iAs: inorganic arsenic; As3mt: arsenic methyltransferase; KO: knockout; 
WT: wild-type.
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Fig. 2. 
Change in body weights of As3mt-KO mice exposed to 0, 15, 20, 25, or 30 mg/L As and 
WT mice exposed to 50 mg/L As. Mean and SD, n = 5 for each of the As3mt-KO group and 
n = 10 for the WT group. There were no statistically significant differences in weekly 
average weights between the treatment groups.
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Fig. 3. 
Oxidation state specific analysis of As in tissues critical for glucose homeostasis. The 
concentration (ng As/g wet tissue) of seven As species in liver (a), adipose tissue (b), 
pancreas (c), and skeletal muscle (d) of As3mt-KO mice exposed to 0, 15, 20, 25, and 30 
mg/L and WT mice exposed to 50 mg/L As as iAsIII. Data is represented as means with SD 
for each arsenical (As3mt-KO, n = 5; WT, n = 10). *Statistically significant difference in 
total speciated As compared to 50 mg/L WT group (p > 0.05).
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Fig. 4. 
Oxidation state specific analysis of circulating As in As3mt-KO mice exposed to 0, 15, 20, 
25, and 30 mg/L As and WT mice exposed to 50 mg/L As as iAsIII. The concentration of As 
species in plasma (a, ng As/mL) and blood cells (b, ng As/g wet tissue). Data is represented 
as means with SD for each arsenical. (As3mt-KO, n = 5; WT, n = 10). * Statistically 
significant difference in total speciated As compared to 50 mg/L WT group (p > 0.05).
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Fig. 5. 
Oxidation state specific analysis of As in tissues from As3mt-KO mice exposed to 0, 15, 20, 
25, and 30 mg/L As and WT mice exposed to 50 mg/L As as iAsIII. The concentration of 
seven As species (ng As/g wet tissue) in intestine with intestinal content (a), kidney (b), lung 
(c), heart (d), brain (e), and testes (f). Data is represented as means with SD for each 
arsenical. (As3mt-KO: n = 5; WT, n = 10).
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Table 1
Determination of equivalent internal As doses in tissues critical for glucose homeostasis.
Treatment group Total speciated Asa (ng As/g tissue)
Pancreas Liver Skeletal muscle Adipose
0 mg/L As3mt-KO 16 (7) 67 (10) 69 (102) 21 (14)
15 mg/L As3mt-KO 381 (38) 3137 (476)# 386 (55) 181 (107)#
20 mg/L As3mt-KO 394 (86) 3525 (787)# 479 (49) 304 (112)#
25 mg/L As3mt-KO 452 (26) 4497 (300)# 677 (114)# 413 (329)#
30 mg/L As3mt-KO 576 (83)# 5564 (1024) 688 (147)# 277 (61)#y
50 mg/L WT 693 (141) 3511 (1174) 658 (185) 239 (118)
a
Total speciated As includes the sum of iAsIII+V, MAsIII+V, DMAsIII+V and TMAsVO determined by HG-CT-AAS. Mean (SD); As3mt-KO, n 
= 5 and WT, n = 10.
#Statistically non-significant difference in total speciated As compared to 50 mg/L WT group (p > 0.05).
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